Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Linkam Scientific continues expansion with new appointments
Linkam Scientific continues expansion with new appointments
Linkam Scientific has made appointments due to steadily expansion across all departments from increasing demand for custom instruments for scientific research
Catalent CFO is inducted as a member of the Executive Leadership Council
Catalent CFO is inducted as a member of the Executive Leadership Council
Wetteny Joseph has joined the council that opens channels of opportunity for the development of black executives to positively impact business and communities
Sophia Genetics chooses new Chairman of the Board of Directors
Sophia Genetics chooses new Chairman of the Board of Directors
Troy Cox will replace Antoine Duchateau as Chairman of the Board of Directors
Optibrium appoints new strategic leader
Optibrium appoints new strategic leader
Tim Hohm has been named new Director of Commercial Strategy and Business Development
Grace Kim joins Rentschler Biopharma US team
Grace Kim joins Rentschler Biopharma US team
Kim has taken the VP Business Development role, strengthening the US presence of the German CDMO
TrakCel co-founder takes the wheel
TrakCel co-founder takes the wheel
Co-founder Dr Fiona Withey has been named as CEO of TrakCel and fellow co-founder Ravi Nalliah as Chief Strategy Officer
DuPont replaces CEO after falling short of 2019 expectations
DuPont replaces CEO after falling short of 2019 expectations
Ex-CEO and executive Chairman Edward Breen has taken back the CEO role at DuPont
CPI CEO passes the torch
CPI CEO passes the torch
Nigel Perry has stepped down as CEO and will be succeeded by COO, Frank Millar
Applied Photophysics makes key appointments
Applied Photophysics makes key appointments
Tim Flanagan has taken the CEO role and Marc Neglia has been promoted to President of Applied Photophysics Inc.
Pathios Therapeutics chooses founding member of Scientific Advisory Board
Pathios Therapeutics chooses founding member of Scientific Advisory Board
Dr Tobias Bopp has been chosen to be the first member of the cancer and autoimmune–focused biotech’s Scientific Advisory Board
Rentschler Biopharma hires new VP for North America and APAC
Rentschler Biopharma hires new VP for North America and APAC
Grace Kim has joined Germany-based CDMO as VP of Business Development for North America and APAC
Former Exyte executive joins BPE
Former Exyte executive joins BPE
Mark Rowland to lead business development at the UK biochemical engineering design company
Enterprise Therapeutics appoints new Chief Medical Officer
Enterprise Therapeutics appoints new Chief Medical Officer
Dr Davis Morris has been appointed to lead Enteprise’s development strategy and drive its two lead respiratory programmes through the clinic
Verona Pharma gets new CEO and COO
Verona Pharma gets new CEO and COO
Respiratory-focused biopharma has appointed David Zaccardelli as President and CEO, and Mark Hahn as COO
NSF International EVP joins regulatory board
NSF International EVP joins regulatory board
The Regulatory Affairs Professionals Society (RAPS) has appointed Kim Trautman to its board of directors
Syntegon Technology names new CEO
Syntegon Technology names new CEO
Dr Michael Grosse has been chosen as the new CEO of Syntegon shortly after changing its name from Bosch Packaging Technology
Previous
1
…
29
30
31
32
(current)
33
34
35
…
214
Next
Trending Articles
Alfa Laval appoints new managing director to drive strategic growth
Alessandro Bracco will lead Alfa Laval UK & Ireland as the company targets growth opportunities across key sectors, including pharmaceutical
How strong leadership transforms regulatory and operational challenges
Why SLTs fail on the PQS/QMS: The leadership gap undermining quality
Entact Bio appoints John G. Houston, Ph.D., to its Board of Directors
A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics
Kindeva appoints Brok Weichbrodt as Chief Transformation Officer to accelerate growth strategy and commercial excellence
Kindeva, a global drug delivery Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Brok Weichbrodt as Chief Transformation Officer to strengthen operational excellence, scale execution, and accelerate growth as the company enters the next phase of its value creation plan
Medicines Discovery Catapult selects prominent UK life sciences leader, Professor Sir Mike Ferguson, as its incoming Chair of the Board
MDC welcomes new Chair from January 2027 to drive impact as next-generation technologies and collaborations reshape drug discovery
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all